CMS boosted Medicare payment for COVID-19 vaccines administered in the patient’s home to $75 per dose, the agency announced June 9. Prior to June 9, Medicare paid $40 per dose for COVID-19 vaccines administered in the patient’s home.Read More »
Jugna J. Shah, MPH, CHRI, discusses why innovative therapies and technologies call for innovations in existing coding, billing, and reimbursement models.Read More »
Ronald Hirsch, MD, FACP, CHCQM, CHRI, examines recent changes to commercial payer prior authorization requirements and how it affects revenue integrity.Read More »
Q: What impact has the COVID-19 public health emergency had on your chargemaster approval process? How did you adapt to chargemaster changes?Read More »
Amy Tepp, CPA, reflects on how key traits of revenue integrity departments—dedication and teamwork—have helped the profession adapt in an evolving industry.Read More »